Wolverine Matrix

Description

BPC-157 + TB-500 Acetate Blend

Contents (per vial):

• TB-500 (Thymosin Beta-4 Fragment) Acetate – 10 mg
• BPC-157 Acetate – 5 mg

Structural Characteristics:
This regenerative peptide formulation combines BPC-157 (Body Protection Compound 157), a 15-amino acid fragment derived from human gastric juice protein, with TB-500, a synthetic version of the naturally occurring thymosin beta-4 peptide fragment. BPC-157 is studied for its angiogenic, anti-inflammatory, and tissue-repair effects, while TB-500 is investigated for its role in actin regulation, cell migration, and wound healing. Together, they target complementary pathways involved in musculoskeletal repair, connective tissue regeneration, and vascular support.

Mechanism of Action (Research Context):
The blend is researched for synergistic effects in:

• Accelerating muscle, tendon, and ligament recovery models
• Enhancing angiogenesis and capillary formation
• Modulating inflammatory response during healing
• Supporting actin cytoskeleton reorganization in cell migration
• Improving joint function and tissue resilience in injury models

Synthesis and Quality Control:

• Both peptides produced via solid-phase peptide synthesis (SPPS)
• HPLC purified to ≥98%
• Verified by Mass Spectrometry (MS)

Product Details:

• Form: Lyophilized acetate salt blend
• Appearance: White to off-white powder
• Supplied in: 3mL sterile vial

Solubility & Reconstitution:
Soluble in sterile water, dilute acetic acid, or aqueous buffers at pH 5–7.

• Swirl gently to dissolve; avoid vigorous shaking
• Protect from oxidation and high pH conditions to preserve peptide integrity

Storage & Handling:

• Store lyophilized powder at –20°C, protected from light and moisture
• After reconstitution, store at 2–8°C for up to 30 days
• For long-term use, aliquot and freeze at –20°C
• Avoid repeated freeze-thaw cycles

Disclaimer:
For research use only. Not for human or veterinary use. Not for diagnostic or therapeutic applications.